Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI Progenitor Cell Translational Consortium (U01)

Notice Number: NOT-HL-15-268

Key Dates
Release Date: August 4, 2015
Estimated Publication Date of Announcement: Fall 2015
First Estimated Application Due Date: Winter 2016
Earliest Estimated Award Date: September 2016
Earliest Estimated Start Date: September 2016

Related Announcements

Issued by
National Heart, Lung, and Blood Institute (NHLBI)


The National Heart, Lung, and Blood Institute intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for research on the translation of advances in progenitor cell biology towards application to heart, lung, and blood diseases.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The FOA is expected to be published in Fall 2015 with an expected application due date in Winter 2016.

This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.

Research Initiative Details

The goal of the intended FOA will be to leverage scientific advances and tools in the fields of progenitor cell biology, genome editing, and bioengineering to develop new treatments for heart, lung, and blood diseases. The FOA solicits multidisciplinary applications from groups of investigators across the different organ-specific disciplines who will come together to translate advances in progenitor cell biology to develop treatment strategies for a specific cardiovascular, pulmonary, or hematologic disease. The investigational group will be expected to include expertise in the chosen focus disease as well as expertise in progenitor cell biology. Other areas of expertise should be included to address the needs for the specific proposal, for example large animal expertise, bioengineering, genome editing, transplant immunology, systems biology, bioreactor expertise for scale-up of cell production, and other areas as needed.



Please direct all inquiries to:

Denis Buxton, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0515